Add this topic to your myFT Digest for news straight to your inbox
Breakthrough medicine will now be subject to further review by committee of independent experts
Sovereign wealth funds Temasek and Mubadala in talks to fund biotech groups harnessing mind-altering substances
Dutch health technology group sets aside €363mn to fix issues with breathing machines
State will be first to capitalise on rules designed to cut high costs Americans pay for drugs
Expect earnings estimates to weaken following the FDA’s safety communication
US and UK regulators say diabetes medication showed ‘significant’ weight loss benefits
BAT subsidiary to challenge regulator’s move against products popular with underage vapers
Drug regulator’s decision is the first step towards a new round of jabs as cases rise in the US
Biotech company rejects founder and Republican presidential hopeful’s criticism of US drug regulator
Food and Drug Administration’s decision is significant development in nationwide battle over reproductive rights
Move by Food and Drug Administration paves way for millions of Americans to access medicine
FDA considers clearing a treatment for Duchenne muscular dystrophy despite lack of ‘unambiguous evidence’ it works
FDA gives green light to C. difficile treatment in boost for microbiome drug developers
If ban becomes permanent, challenges to FDA’s authority by special interest groups could proliferate
Industry figures warn judge’s decision could put medical innovation at risk
Pharma groups and legal experts fear fallout if Texas court overturns regulatory approval after 23 years
Committees cite inappropriate collaboration between FDA and drugmaker
High production costs together with increasingly vegetarian appetites may prevent this industry taking off
FDA clears jabs despite lack of human trials in effort to curb winter wave of Covid infections
Shares in French pharma group tumble nearly 6% after blow to pipeline of new treatments
Supplies were intended to help with months-long shortage in America
Change would incorporate genetic material from fast-spreading strain in new boosters
Regulator cites teen vaping in decision against the country’s market leader
US prepares to roll out jabs to last age group without access once regulatory approval is received
Protein-based vaccine is an alternative to mRNA technology used by BioNTech/Pfizer and Moderna
International Edition